Hims & Hers Health (HIMS) EBIT Margin Growth (1y) (2021 - 2026)

Hims & Hers Health (HIMS) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 304.00
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -157.00
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -650.00
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -2,102.00
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1,962.00
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 152.00
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -12,673.00
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -583.00
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -2,276.00
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 118,171.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,276.00
Dec 31, 2025 -238.00
Sep 30, 2025 -360.00
Jun 30, 2025 141.00
Mar 31, 2025 632.00
Dec 31, 2024 403.00
Sep 30, 2024 935.00
Jun 30, 2024 794.00
Mar 31, 2024 946.00
Dec 31, 2023 678.00
Sep 30, 2023 1,002.00
Jun 30, 2023 1,334.00
Mar 31, 2023 1,080.00
Dec 31, 2022 1,852.00
Sep 30, 2022 2,350.00
Jun 30, 2022 1,090.00
Mar 31, 2022 7,584.00
Dec 31, 2021 -1,430.00
Sep 30, 2021 -2,926.00
Jun 30, 2021 -2,595.00